Getting Your Investigational Drug Regulatory Ready

You have a new biotherapeutic in development that has shown promise in pre-clinical studies against a life-threatening disease. Affected patients and their providers are anxiously awaiting a new treatment option. How do you get your drug into the clinic quickly? Navigating regulatory requirements can be overwhelming. Here, we map out basic information to help you approach regulatory policies and offer helpful strategies to facilitate efficient regulatory review and drug approval.